Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
5 trials
Recent
Start date
Enrollment
Multiple Endocrine Neoplasia Type 1
×
Fulvestrant
×
Clear all
Filters
2
NCT05631795
2025-12-03
ALPINIST
Novartis
Phase 4
Completed
40 enrolled
NCT04300790
2025-07-29
METALLICA
MedSIR
Phase 2
Completed
69 enrolled
NCT02437318
2025-02-13
SOLAR-1
Novartis
Phase 3
Completed
572 enrolled
22 charts
1 FDA
NCT02422615
2023-11-30
MONALEESA-3
Novartis
Phase 3
Completed
726 enrolled
17 charts
1 FDA
NCT02753686
2023-02-15
Treat ER+ight
Novartis
Completed
440 enrolled